Presentation Information
[EMO7-5]Investigation of optimal treatment after induction immune checkpoint inhibitor combination chemotherapy for locally advanced unresectable esophageal cancer.
Yasuaki Nakajima1,2, Kazuo Ogiya1,2, Yumiko Hayashi2, Fumio Tsukamoto2, Yutaka Nakata2, Noriko Iwata2, Haruhisa Endo2, Ichiro Saeki2, Sadao Takahashi2 (1.Esophageal Disease Center, Edogawa Hospital, 2.Department of Surgery, Edogawa Hospital)
Password required to view
Comment
To browse or post comments, you must log in.Log in